These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 2393341)

  • 1. Standardized assessment of personality disorders in obsessive-compulsive disorder.
    Baer L; Jenike MA; Ricciardi JN; Holland AD; Seymour RJ; Minichiello WE; Buttolph ML
    Arch Gen Psychiatry; 1990 Sep; 47(9):826-30. PubMed ID: 2393341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ten-year stability and latent structure of the DSM-IV schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders.
    Sanislow CA; Little TD; Ansell EB; Grilo CM; Daversa M; Markowitz JC; Pinto A; Shea MT; Yen S; Skodol AE; Morey LC; Gunderson JG; Zanarini MC; McGlashan TH
    J Abnorm Psychol; 2009 Aug; 118(3):507-19. PubMed ID: 19685948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gambling disorder and obsessive-compulsive personality disorder: A frequent but understudied comorbidity.
    Medeiros GC; Grant JE
    J Behav Addict; 2018 Jun; 7(2):366-374. PubMed ID: 29936850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of obsessive-compulsive personality disorder symptoms in Internet users.
    Chamberlain SR; Redden SA; Stein DJ; Lochner C; Grant JE
    Ann Clin Psychiatry; 2017 Aug; 29(3):173-181. PubMed ID: 28738097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two-year stability and change of schizotypal, borderline, avoidant, and obsessive-compulsive personality disorders.
    Grilo CM; Sanislow CA; Gunderson JG; Pagano ME; Yen S; Zanarini MC; Shea MT; Skodol AE; Stout RL; Morey LC; McGlashan TH
    J Consult Clin Psychol; 2004 Oct; 72(5):767-75. PubMed ID: 15482035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of obsessive-compulsive personality disorder scales.
    Samuel DB; Widiger TA
    J Pers Assess; 2010 May; 92(3):232-40. PubMed ID: 20408023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Non-suicidal self-injurious behavior in conduct disorders and schizotypal disorder].
    Khutoryanskaya JV; Grechanyy SV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2023; 123(9. Vyp. 2):69-76. PubMed ID: 37942975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between personality disorders and characteristics of multiple sclerosis patients and their parents.
    Nazari Kamal M; Samouei R; Sarrafzadeh S; Tamannaeifar S; Ghaebi N; Behrouzi R
    J Educ Health Promot; 2018; 7():106. PubMed ID: 30159352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological interventions for obsessive-compulsive personality disorder.
    Alex R; Ferriter M; Jones H; Huband N; Duggan C; Völlm BA; Stoffers J; Lieb K
    Cochrane Database Syst Rev; 2010; (5):. PubMed ID: 25267900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Personality Disorders: A Once and Future (Nonbinary) King/Queen.
    Choi-Kain LW
    Focus (Am Psychiatr Publ); 2022 Oct; 20(4):335-336. PubMed ID: 37200884
    [No Abstract]   [Full Text] [Related]  

  • 11. Obsessive-compulsive (Anankastic) Personality Disorder: A Poorly Researched Landscape with Significant Clinical Relevance.
    Reddy MS; Vijay MS; Reddy S
    Indian J Psychol Med; 2016; 38(1):1-5. PubMed ID: 27011394
    [No Abstract]   [Full Text] [Related]  

  • 12. Personality disorder.
    Bax OK; Chartonas D; Parker J; Symniakou S; Lee T
    BMJ; 2023 Sep; 382():e050290. PubMed ID: 37666510
    [No Abstract]   [Full Text] [Related]  

  • 13. General personality dimensions, impairment and treatment response in obsessive-compulsive disorder.
    Samuels J; Bienvenu OJ; Krasnow J; Wang Y; Grados MA; Cullen B; Goes FS; Maher B; Greenberg BD; Mclaughlin NC; Rasmussen SA; Fyer AJ; Knowles JA; Mccracken JT; Piacentini J; Geller D; Stewart SE; Murphy DL; Shugart YY; Riddle MA; Nestadt G
    Personal Ment Health; 2020 May; 14(2):186-198. PubMed ID: 31859455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psychopharmacological Treatment of Obsessive-Compulsive Disorder (OCD).
    Del Casale A; Sorice S; Padovano A; Simmaco M; Ferracuti S; Lamis DA; Rapinesi C; Sani G; Girardi P; Kotzalidis GD; Pompili M
    Curr Neuropharmacol; 2019; 17(8):710-736. PubMed ID: 30101713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obsessive-compulsive disorder in children and adolescents. A 6-22-year follow-up study. Clinical descriptions of the course and continuity of obsessive-compulsive symptomatology.
    Per Thomsen H
    Eur Child Adolesc Psychiatry; 1994 Apr; 3(2):82-96. PubMed ID: 29871466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obsessive-compulsive disorder in children and adolescents. A review of the literature.
    Thomsen PH
    Eur Child Adolesc Psychiatry; 1994 Jul; 3(3):138-158. PubMed ID: 29871422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comorbid Personality Disorders in Obsessive-Compulsive Disorder and Its Symptom Dimensions.
    Bulli F; Melli G; Cavalletti V; Stopani E; Carraresi C
    Psychiatr Q; 2016 Jun; 87(2):365-76. PubMed ID: 26442944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological interventions for obsessive-compulsive personality disorder.
    Alex R; Ferriter M; Jones H; Duggan C; Huband N; Gibbon S; Völlm BA; Stoffers J; Lieb K
    Cochrane Database Syst Rev; 2010; (5):. PubMed ID: 25267901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Personality disorders in obsessive-compulsive disorder: a comparative study versus other anxiety disorders.
    Pena-Garijo J; Edo Villamón S; Meliá de Alba A; Ruipérez MÁ
    ScientificWorldJournal; 2013; 2013():856846. PubMed ID: 24453917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temperament features in adolescents with ego-syntonic or ego-dystonic obsessive-compulsive symptoms.
    Marchesi C; Ampollini P; DePanfilis C; Maggini C
    Eur Child Adolesc Psychiatry; 2008 Sep; 17(6):392-6. PubMed ID: 18427866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.